BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Jun 15, 2026; 18(6): 120007
Published online Jun 15, 2026. doi: 10.4251/wjgo.v18.i6.120007
Table 2 Comparison between non-prolonged postoperative ileus and prolonged postoperative ileus groups, n (%)
Variable
Non-PPOI (n = 118)
PPOI (n = 49)
SMD
P value
Sex-0.520
    Male49 (41.5)23 (46.9)
    Female69 (58.5)26 (53.1)
Age (years)71.7 ± 5.470.9 ± 8.80.1130.504
BMI (kg/m2)23.8 ± 3.324.2 ± 3.20.1380.415
Smoking history40 (33.9)17 (34.7)-0.921
History of abdominal surgery18 (15.3)9 (18.4)-0.619
Coronary heart disease19 (16.1)7 (14.3)-0.768
mFI-5 ≥ 240 (33.9)31 (63.3)-< 0.001
Preop CEA (ng/mL)3.74 (2.09-10.3)4.33 (2.52-7.42)0.1040.699
Preoperative albumin (g/L)38.35 (36.1-41.2)38 (35.3-41.1)0.1330.684
AJCC staging-0.251
    I15 (12.7)11 (22.5)
    II54 (45.8)18 (36.7)
    III49 (41.5)20 (40.8)
ASA score-0.080
    I2 (1.7)1 (2)
    II87 (73.7)28 (57.1)
    III29 (24.6)20 (40.8)
Auxiliary incision length (cm)5 (5-5)5 (5-5)0.1200.401
Operation time (minute)176 ± 50168 ± 60.90.1510.374
Tumor location-0.167
    Rectal cancer87 (73.7)41 (83.7)
    Colon cancer31 (26.3)8 (16.3)
Lymphovascular/perineural invasion36 (30.5)12 (24.5)-0.434
Postoperative opioid use-0.008
    Yes39 (33.1)27 (55.1)
    No79 (66.9)22 (44.9)
Postoperative albumin (g/L)32.7 (31-35.08)32.06 (30.3-33.96)0.0930.129
    POD 1 fluid (mL)3611 (2900-4100)3660 (2766-4130)0.0260.934
    POD 2 fluid (mL)3494 (2880-3930)3300 (2844-3890)0.1750.340
    POD 3 fluid (mL)3465 (2780-4000)3320 (2800-3936)0.1240.566
    POD 1 K+ (mmol/L)4.265 (4-4.5)4.1 (3.63-4.4)0.4990.012
    POD 1 Ca2+ (mmol/L)2.03 (1.96-2.12)2.01 (1.94-2.11)0.0850.402
    POD 1 NLR9.035 (7.6-12.6)8.4 (6.91-11.38)0.1790.141
    POD 1 PNI37.54 (35.1-40.52)37.55 (35.11-39.9)0.0250.965
    POD 1 SII1866.215 (1321.88-2471.95)1683.44 (1156.09-2238.31)0.2740.174
    POD 1 PIV1238.155 (749.32-2038.9)1071.18 (704.18-1790.47)0.0540.551


Write to the Help Desk